Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
20/08/2026 07:51
BRIEF-Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln Aug 20 (Reuters) - Guard Therapeutics International AB (publ) GUARD.ST:
Q2 NET SALES 0 KSEK; PROFIT BEFORE AND AFTER TAX -4,364 KSEK; EPS -0.22 SEK
Source text: ID:nMFN1Wpxl9
Further company coverage: GUARD.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Disruptive Pharma AB (publ)
See all newsBrief: Disruptive Pharma To Sell GTX Platform To Aurelia Invest AB Unit
Brief: Guard Therapeutics International Q2 Loss Before Tax SEK 4.4 Mln
Brief: Guard Therapeutics Gets Conditional Approval For Continued Listing
Brief: Guard Therapeutics International Initiates Deal Process For Gtx Platform
Brief: Guard Therapeutics Enters Conditional Deal For Reverse Takeover